Search Results for:
-
Definitions, Methodology And Footnotes For CEO Data
Definitions & Methodology The data presented in these tables were obtained from proxy statements and annual reports of 231 biotechnology companies that were filed with the U.S. Securities and Exchange Commission (SEC). Unless otherwise noted with symbols, companies had a fiscal year-end of Dec. 31, 2003. Numbered footnotes containing important details appear following this section. IMPORTANT NOTE: The CEO listed for 231 companies is the individual who held that title for the majority of the -
BioWorld Survey of 231 Biotechnology Companies By Year of Initial Public Offering
-
Median Legal Officer Compensation Package (Total Direct Compensation)
For Legal Executives Who Received A Full Year Of Salary, 64 Companies -
Median Business And Corporate Development Compensation Package (Total Direct Compensation)
For Business And Corporate Development Executives Who Received A Full Year Of Salary, 51 Companies -
Median R&D Executive Compensation Package (Total Direct Compensation)
For R&D Executives Who Received A Full Year Of Salary, 121 Companies -
Median CFO Compensation Package (Total Direct Compensation)
For CFOs Who Received A Full Year Of Salary, 167 Companies -
Median Annual CEO Compensation By Year of Initial Public Offering
For CEOs Who Received A Full Year Of Salary, 214 Companies -
Median Annual CEO Compensation By Market Capitalization Of Company
For CEOs Who Received A Full Year Of Salary, 214 Companies -
Median CEO Compensation Package (Total Direct Compensation)
For CEOs Who Received A Full Year Of Salary, 214 Companies -
Median Annual CEO Compensation (Base Salary Plus Bonus)
For CEOs Who Received A Full Year Of Salary, 214 Companies -
Introduction To BioWorld's 2005 Executive Compensation Report On The Biotechnology Industry
2003 treated biotechnology executives fairly well. CEO salaries and bonuses rose in 2003, and the average biotechnology CEO, by BioWorld's calculations, took home more than half a million dollars in pay and bonuses. In fact, pay rose modestly for CEOs, chief financial officers and business development executives. However, for science and legal executives, the year was less kind - the average legal representative in 2003 suffered a nearly 2 percent pay cut (salary plus bonus), and the average -
CEOs Ranked By Annual Compensation For The 202 CEOs In BioWorld's 225-Company Survey Who Received A Full Year Of Compensation (Base Salary Plus Bonus)
Rank Name of Executive Company Base Salary ($000) Bonus ($000) Total ($000) Stock Price 12/31/02 ($000) Shares Out (M) Approx. Mkt. Cap. 12/31/02 ($M) 1 Frank Baldino, Jr. (29) Cephalon Inc. 800 2,409 3,209 48.66 55.5 2,700.20 2 Kevin W. Sharer (11) Amgen Inc. 980 1,800 2,780 48.34 1,301.10 62,894.20 3 David M. Mott MedImmune Inc. 833 1,200 2,033 27.17 251.8 6,840.30 4 Sean P. Lance (31) Chiron Corp. 777 1,250 2,027 37.6 186.4 7,007.90 5 Arthur D -
Alphabetical Listing Of CEO Compensation Packages By Company
Company Name of Executive Age Base Salary ($000) Bonus ($000) Total ($000) Other ($000) Long-Term Compensation ($000) Total Direct Compensation ($000) Base Salary Prior FY ($000) Percent Change Base Salary (%) Potential Realizable Value of Option Grants ($000) FYE Value of Exercisable In-the-Money Options ($000) Percent of Co. Stock Owned By CEO (%) Cum. Total Return on Investment ($) Stock Price 12/31/01 ($) Stock Price 12/31/02 ($) Percent Change Stock Price (%) Shares Out (M -
Alphabetical Listing Of CFO Compensation Packages By Company
Company Name of Executive Base Salary ($000) Bonus ($000) Total ($000) Other ($000) Long-Term Comp. ($000) Total Direct Comp. ($000) Potential Realizable Value of Option Grants ($000) FYE Value of Exercisable In-the-Money Options ($000) Aastrom Biosciences Inc.** Michael S. Durski (1) 68 0 68 0 0 68 144 0 Abgenix Inc. Kurt Leutzinger 273 0 273 6 183 462 424 521 Aclara BioSciences Inc. Alfred G. Merriweather 203 10 213 0 0 213 0 0 Adolor Corp. Peter J -
CFOs Ranked By Annual Compensation For The 143 CFOs In BioWorld's 225-Company Survey Who Received A Full Year Of Compensation (Base Salary Plus Bonus)
Rank Name of Executive Company Base Salary ($000) Bonus ($000) Total ($000) 1 Richard D. Nanula (4) Amgen Inc. 617 971 1,588 2 J. Kevin Buchi Cephalon Inc. 336 425 761 3 Louis J. Lavigne, Jr. (28) Genentech Inc. 387 325 712 4 Daniel S. Lynch (36) ImClone Systems Inc. 352 360 712 5 James R. Sulat Chiron Corp. 397 300 697 6 Robert J. Hugin Celgene Corp. 372 210 582 7 Stephen L. Zaniboni (77) Sequenom Inc. 270 263 533 8 Peter N. Kellogg (6) Biogen -
Alphabetical Listing Of R&D Executive Compensation Packages By Company
Company Name of Executive Base Salary ($000) Bonus ($000) Total ($000) Other ($000) Long-Term Comp. ($000) Total Direct Comp. ($000) Potential Realizable Value of Option Grants ($000) FYE Value of Exercisable In-the-Money Options ($000) Abgenix Inc. C. Geoffrey Davis 269 0 269 0 0 269 424 941 Adolor Corp. David Jackson 311 65 376 77 0 453 514 17 Alexion Pharmaceuticals Inc. Stephen P. Squinto (1) 216 35 251 5 0 256 0 1,466 Alkermes Inc.** James L. Wright -
R&D Executives Ranked By Annual Compensation For The 130 R&D Executives In BioWorld's 225-Company Survey Who Received A Full Year Of Compensation (Base Salary Plus Bonus)
Rank Company Name of Executive Base Salary ($000) Bonus ($000) Total ($000) 1 Amgen Inc. Roger M. Perlmutter (5) 683 1,276 1,959 2 MedImmune Inc. James F. Young 488 450 938 3 Gilead Sciences Inc. Norbert W. Bischofberger (42) 430 315 745 4 Incyte Corp. Robert B. Stein (47) 500 242 742 5 Cephalon Inc. Paul Blake (15) 325 404 729 6 Sequenom Inc. Charles R. Cantor 301 293 594 7 Genentech Inc. Richard H. Scheller (36) 342 250 592 8 Human Genome -
Vital Statistics
For The Public Biotechnology Companies In BioWorld's Survey Number of companies: 225 Total Market Capitalization of the 225 companies on Dec. 31, 2002: $177.1 billion Average Market Capitalization per company on Dec. 31, 2002: $787.2 million Median Market Capitalization per company on Dec. 31, 2002: $108.3 million Smallest Market Capitalization on 12/31/02: $704,767 (Incara Pharmaceuticals Corp.) Largest Market Capitalization on 12/31/02: $62.9 billion (Amgen Inc.) Total Shares -
Alphabetical Listing Of Legal Officer Compensation Packages By Company
Company Name of Executive Base Salary ($000) Bonus ($000) Total ($000) Other ($000) Long-Term Comp. ($000) Total Direct Comp. ($000) Potential Realizable Value of Option Grants ($000) FYE Value of Exercisable In-the-Money Options ($000) Abgenix Inc. Susan L. Thorner (1) 250 0 250 0 0 250 253 0 Adolor Corp. Martha E. Manning 97 50 147 2 0 149 635 48 Affymetrix Inc. Barbara A. Caulfied (2) 350 193 543 0 0 543 0 507 Alexion Pharmaceuticals Inc. Thomas I.H -
Legal Officers Ranked By Annual Compensation For The 67 Legal Officers In BioWorld's 225-Company Survey Who Received A Full Year Of Compensation (Base Salary Plus Bonus)
Rank Name of Executive Company Base Salary ($000) Bonus ($000) Total ($000) 1 Stuart J. Swiedler BioMarin Pharmaceutical Inc. 2542 0 2,542 2 William G. Green (7) Chiron Corp. 452 450 902 3 John E. Osborn (6) Cephalon Inc. 320 420 740 4 Peter Wirth (16) Genzyme Corp. 565 83 648 5 Stephen G. Juelsgaard (13) Genentech Inc. 342 275 617 6 Barbara A. Caulfied (2) Affymetrix Inc. 350 193 543 7 Thomas J. Bucknam Biogen Inc. 335 159 494 8 Lee Bendekgey